[Fibrosis indexes reduce the need of liver biopsy in chronic hepatitis C].
Johan Björklund(Karolinska University Hospital), Ola Weiland(Karolinska University Hospital), Soo Aleman(Karolinska University Hospital)
PubMed
June 8, 2009
Cited by 0
Related Papers
Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
|New England Journal of Medicine|2014|907
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
|Journal of Viral Hepatitis|2014|484
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
|The Lancet. Gastroenterology & hepatology|2023|399
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
|Nature Immunology|2023|281
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication
|Journal of Hepatology|2016|273